Since their introduction 20 years ago, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionised the treatment of diabetes and obesity. Known for their immunomodulatory and ...
Psoriasis and psoriatic arthritis (PsA) are chronic, immune-mediated inflammatory diseases associated with several shared common comorbidities, of which obesity is one of the most prevalent. A complex ...
The KaiNETIC global Phase 3 clinical program includes three global, double-blind, randomized, placebo-controlled Phase 3 trials (KaiNETIC-1, KaiNETIC-2, and KaiNETIC-3) to evaluate weekly ribupatide ...
The landscape of weight management has evolved dramatically in recent years, with GLP-1 receptor agonists like Semaglutide leading the way in treating obesity. However, a new contender has emerged: ...
SEATTLE -- GLP-1 receptor agonist use was tied with a reduced risk for fracture among older women with type 2 diabetes, a retrospective cohort study found. Among over 350,000 GLP-1 users, there was a ...
MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...
Please provide your email address to receive an email when new articles are posted on . Hidradenitis suppurativa is associated with repeat surgeries and hospitalizations. GLP-1 receptor agonist ...
Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 agonists like Ozempic are primarily used to treat type 2 diabetes. Its popularity has even influenced wholesale retailer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results